Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?-Reference-Cited by-同舟云学术

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

Published:2021-09-08 Issue:11 Volume:70 Page:2196-2204
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

van Baar Annieke C G,Meiring Suzanne,Holleman Frits,Hopkins David,Mingrone Geltrude^ORCID,Devière Jacques,Nieuwdorp Max^ORCID,Bergman Jacques J G H M^ORCID

Publisher

BMJ

Subject

Gastroenterology

Reference48 articles.

1. The National Diabetes Register in Sweden

2. NHS Digital . National diabetes audit programme, 2021. Available: https://digital.nhs.uk/data-and-information/clinical-audits-and-registries/national-diabetes-audit

3. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021

4. Effects of a combined dietary, exercise and behavioral intervention and sympathetic system on body weight maintenance after intended weight loss: results of a randomized controlled trial;Mai;Metabolism,2018

5. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study;Obesity,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neuroprotective role of celastrol on hippocampus in diabetic rats by inflammation restraint, insulin signaling adjustment, Aβ reduction and synaptic plasticity alternation;Biomedicine & Pharmacotherapy;2024-10

2. Highly functional duodenal stent with photosensitizers enables photodynamic therapy for metabolic syndrome treatment: Feasibility and safety study in a porcine model;APL Bioengineering;2024-07-02

3. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes;Peptides;2024-04

4. Role of the Intestine and Its Gut Microbiota in Metabolic Syndrome and Obesity;American Journal of Gastroenterology;2024-03-28

5. Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease;European Journal of Internal Medicine;2023-11